• Highlights
• Introduction
• Causes
• Symptoms
• Risk Factors
• Complications
• Diagnosis
• Dietary Considerations
• Symptom Management
• Medications
• Surgical Procedures
• Resources
• References

Ulcerative colitis

Description

An in-depth report on the causes, diagnosis, treatment, and prevention of ulcerative colitis.

Alternative Names

Inflammatory bowel disease; Colitis - ulcerative

Highlights

Drug Approval

Infliximab (Remicade) was approved in 2005 for treatment of adults with ulcerative colitis. It is the first biologic drug approved for ulcerative colitis (UC). According to results published in the New England Journal of Medicine , infliximab helped patients with moderate-to-severe UC achieve and maintain remission.

Quality of Life

UC symptoms impact many patients’ quality of life, according to a 2005 survey. Survey results indicated:

• UC symptoms can interfere with work, family, and social situations.
• 40% of patients with UC experience severe symptoms 180 days per year.
• Patients with UC feel that their condition is misunderstood and underestimated by family, friends, and co-workers.

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

NSAIDS such as acetaminophen (Tylenol), naproxen (Aleve), and celecoxib (Celebrex) are as safe for patients with UC as for other people, according to several 2006 studies. The studies found that NSAIDs may provide pain relief and prevent symptom relapse. However, patients should always discuss NSAID use with their doctors.

Complications

Patients with UC have an increased risk of developing other inflammatory and autoimmune conditions such as arthritis, asthma, bronchitis, psoriasis, and multiple sclerosis.

Colorectal Cancer and Ulcerative Colitis

• Patients with UC have an increased risk of developing colorectal cancer. The longer a patient has UC, and the more severe the condition, the greater the risk for cancer.
• Regular colonoscopy exams, and some types of anti-inflammatory drugs, may help reduce cancer risk.
• Patients with UC who develop colorectal cancer have a poorer survival outlook than those without UC.

Surgery

Ileal pouch anal anastomosis (IPAA) surgery triples the risk of infertility in women who have the procedure, indicates a 2006 study. Doctors think that the surgery may scar and block the fallopian tubes, making it more difficult for women to conceive.

• Review Date: 8/23/2006
• Reviewed By: Harvey Simon, M.D., Editor-in-Chief, Associate Professor of Medicine, Harvard Medical School; Physician, Massachusetts General Hospital

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process . A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997-2007 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.